Male
Dr. Liu is a Vice President at Longitude Capital. Prior to joining Longitude Capital in 2018, Dr. Liu was an Engagement Manager in the pharmaceuticals and medical products practice of McKinsey & Company, where he advised clients in the biotechnology and medical device industries. Dr. Liu is a board observer at Inflazome. Dr. Liu holds an M.D. from Stanford School of Medicine and a B.S. in Biomedical Engineering from The Johns Hopkins University.
Headlines from Google News. Social posts load from the platform only when you open a tab.
Stock Titan · Aug 4
BioPharm International · Nov 18
Endpoints News · Nov 12
Business Wire · Nov 12
Fierce Biotech · Jan 30